Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aberg

Showing results (401-410 of 424) with videos related to

Pageof 43
Sort By:
Vaccine|June 30, 2026
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adultsSean T H Liu, Irene González-Domínguez, Amparo Martínez-Pérez, et al.
HIV Research & Clinical Practice|March 13, 2020
Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordinationKathleen V Fitch, Emma M Kileel, Sara E Looby, et al.
Journal of Clinical Lipidology|December 25, 2015
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2Terry A Jacobson, Kevin C Maki, Carl E Orringer, et al.
JAMA Cardiology|February 21, 2024
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical TrialMichael T Lu, Heather Ribaudo, Borek Foldyna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 6, 2025
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE TrialLiying Xue, Romit Bhattacharya, Md Mesbah Uddin, et al.
The New England Journal of Medicine|July 24, 2023
Pitavastatin to Prevent Cardiovascular Disease in HIV InfectionSteven K Grinspoon, Kathleen V Fitch, Markella V Zanni, et al.
Nature Medicine|September 16, 2020
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control studySean T H Liu, Hung-Mo Lin, Ian Baine, et al.
Nature Medicine|August 26, 2020
An inflammatory cytokine signature predicts COVID-19 severity and survivalDiane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, et al.
The Lancet. HIV|March 30, 2026
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVEEmma M Kileel, Carlos D Malvestutto, Markella V Zanni, et al.
Science Immunology|October 25, 2024
Gastrointestinal germinal center B cell depletion and reduction in IgA<sup>+</sup> plasma cells in HIV-1 infectionFrancesca Cossarini, Joan Shang, Azra Krek, et al.
Pageof 43

Showing results (401-410 of 424) with videos related to

Sort By:
Pageof 43
Vaccine|June 30, 2026
Phase 1 trial of intranasal NDV-HXP-S in previously vaccinated adultsSean T H Liu, Irene González-Domínguez, Amparo Martínez-Pérez, et al.
HIV Research & Clinical Practice|March 13, 2020
Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: critical role of central coordinationKathleen V Fitch, Emma M Kileel, Sara E Looby, et al.
Journal of Clinical Lipidology|December 25, 2015
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2Terry A Jacobson, Kevin C Maki, Carl E Orringer, et al.
JAMA Cardiology|February 21, 2024
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical TrialMichael T Lu, Heather Ribaudo, Borek Foldyna, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 6, 2025
Clonal Hematopoiesis and Major Adverse Cardiac Events in People With HIV: Insights From the REPRIEVE TrialLiying Xue, Romit Bhattacharya, Md Mesbah Uddin, et al.
The New England Journal of Medicine|July 24, 2023
Pitavastatin to Prevent Cardiovascular Disease in HIV InfectionSteven K Grinspoon, Kathleen V Fitch, Markella V Zanni, et al.
Nature Medicine|September 16, 2020
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control studySean T H Liu, Hung-Mo Lin, Ian Baine, et al.
Nature Medicine|August 26, 2020
An inflammatory cytokine signature predicts COVID-19 severity and survivalDiane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, et al.
The Lancet. HIV|March 30, 2026
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVEEmma M Kileel, Carlos D Malvestutto, Markella V Zanni, et al.
Science Immunology|October 25, 2024
Gastrointestinal germinal center B cell depletion and reduction in IgA<sup>+</sup> plasma cells in HIV-1 infectionFrancesca Cossarini, Joan Shang, Azra Krek, et al.
Pageof 43